Scynexis Prepares To Launch Brexafemme In Vaginal Yeast Infections, Priced At $475

 
• By Joseph Haas
  
Rocket takes off from the hand of the businessman. Concept of start up.
Scynexis is readying launch of its novel anti-fungal for vaginal yeast infections
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business